Collagen-Binding Integrins as Pharmaceutical Targets
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
867-880
Author(s):
Johannes A. Eble
Integrins: Regulators of Tissue Function and Cancer Progression
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
881-891
Author(s):
Erik H.J. Danen
Topotecan and Irinotecan in the Treatment of Pediatric Solid Tumors
Journal:
Current Pediatric Reviews
Volume:
1
Page:
55-61
Author(s):
Yoshiaki Tsuchida and Toshiji Shitara
Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
621-635
Author(s):
Ravi D. Rao, Jan C. Buckner and Jann N. Sarkaria
Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
653-671
Author(s):
Hue H. Luu, Ruiwen Zhang, Rex C. Haydon, Elizabeth Rayburn, Quan Kang, Weike Si, Jong Kyung Park, Hui Wang, Ying Peng, Wei Jiang and Tong- Chuan He
Surface Antigens/Receptors for Targeted Cancer Treatment: The GnRH Receptor / Binding Site for Targeted Adenocarcinoma Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
673-687
Author(s):
R. Eaveri, A. Ben-Yehudah and H. Lorberboum-Galski
An Expanding Appreciation of the Role Chemokine Receptors Play in Cancer Progression
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2377-2389
Author(s):
O.M. Zack Howard and Carole L. Galligan
Deubiquitinating Enzymes: Their Functions and Substrate Specificity
Journal:
Current Protein & Peptide Science
Volume:
5
Page:
191-200
Author(s):
Tatiana A. Soboleva and Rohan T. Baker
Porphyrins as Radiosensitizing Agents for Solid Neoplasms
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2024-2035
Author(s):
M. Schaffer, B. Ertl-Wagner, P. M. Schaffer, U. Kulka, A. Hofstetter, E. Duhmke and G. Jori
Roles of Growth Factors in Chemotherapy-Induced Intestinal Mucosal Damage Repair
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
260-269
Author(s):
C. J. Xian